whi p154 has been researched along with Neoplasms in 1 studies
WHI P154: an anti-leukemic agent; structure in first source
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sudbeck, EA | 1 |
| Ghosh, S | 1 |
| Liu, XP | 1 |
| Zheng, Y | 1 |
| Myers, DE | 1 |
| Uckun, FM | 1 |
1 review available for whi p154 and Neoplasms
| Article | Year |
|---|---|
Tyrosine kinase inhibitors against EGF receptor-positive malignancies.
Topics: Adenocarcinoma; Amides; Aniline Compounds; Animals; Antineoplastic Agents; Breast Neoplasms; Drug De | 2001 |